Boczar Krzysztof, Sławuta Agnieszka, Ciesielski Adam, Dębski Maciej, Ulman Mateusz, Golińska-Grzybała Karolina, Gajek Jacek, Lelakowski Jacek, Ząbek Andrzej
Department of Electrocardiology, The John Paul II Hospital, Kraków, Poland.
Department of Cardiology, Klodzko County Hospital, Kłodzko, Poland.
Kardiol Pol. 2024;82(9):870-873. doi: 10.33963/v.phj.101556. Epub 2024 Jul 30.
Nowadays, we observe a growing interest in conduction system pacing (CSP). Therefore, we expect the number of patients with CSP to increase significantly in the coming years. However, there is a lack of large data on transvenous lead extraction (TLE) procedures of CSP leads, particularly His bundle pacing (HBP) leads in the adult population.
This study aimed to present the experience of performing TLE procedures in patients with CSP leads using a non-stylet-driven Medtronic 3830 lead in two tertiary lead extraction centers in Poland.
A prospective analysis of the records involved of all patients with HBP leads who underwent TLE from October 2011 to November 2023.
The study involved 38 patients, at a median (interquartile range [IQR]) age of 69.7 (65.6-76.0) years, 8 of whom were female (21.1%). The median (IQR) lead dwell time was 15.5 (8.7-19.8) months. Thirty leads were removed using simple traction, while 8 leads required mechanical extraction tools. All leads with lead dwell time over 42 months required mechanical extraction tools. The median (IQR) fluoroscopy time was 1.03 (0.07-11.5) min. There were no intra-procedural major or minor complications. Radiological and clinical success was achieved in 100% of targeted CSP leads.
TLE from the His bundle and left bundle branch region is a safe and effective procedure, with no lasting damage to the His-Purkinje system. Successful re-implantation of the lead in the His-Purkinje conduction system is possible in most cases.
如今,我们注意到对传导系统起搏(CSP)的兴趣日益浓厚。因此,我们预计未来几年接受CSP治疗的患者数量将显著增加。然而,目前缺乏关于CSP导线经静脉拔除(TLE)手术的大量数据,尤其是在成年人群中的希氏束起搏(HBP)导线。
本研究旨在介绍在波兰两个三级导线拔除中心,使用非探条驱动的美敦力3830导线对植入CSP导线的患者进行TLE手术的经验。
对2011年10月至2023年11月期间所有接受HBP导线TLE手术的患者记录进行前瞻性分析。
该研究纳入了38例患者,年龄中位数(四分位间距[IQR])为69.7(65.6 - 76.0)岁,其中8例为女性(21.1%)。导线中位(IQR)植入时间为15.5(8.7 - 19.8)个月。30根导线通过简单牵引拔除,8根导线需要使用机械拔除工具。所有植入时间超过42个月的导线均需使用机械拔除工具。透视时间中位数(IQR)为1.03(0.07 - 11.5)分钟。术中无重大或轻微并发症。100%的目标CSP导线实现了影像学和临床成功。
从希氏束和左束支区域进行TLE是一种安全有效的手术,对希氏 - 浦肯野系统无持久损伤。大多数情况下,导线能够成功重新植入希氏 - 浦肯野传导系统。